Intuitive Surgical (ISRG) Stock Forecast & Price Target

$544.72 +1.12 (+0.21%)

(As of 12/12/2024 05:56 PM ET)

Intuitive Surgical - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy

Based on 19 Analyst Ratings

Sell
1

Hold
3

Buy
15

Based on 19 Wall Street analysts who have issued ratings for Intuitive Surgical in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 19 analysts, 1 has given a sell rating, 3 have given a hold rating, and 15 have given a buy rating for ISRG.

Consensus Price Target

$550.28
1.02% Upside

According to the 19 analysts' twelve-month price targets for Intuitive Surgical, the average price target is $550.28. The highest price target for ISRG is $650.00, while the lowest price target for ISRG is $375.00. The average price target represents a forecasted upside of 1.02% from the current price of $544.72.

Get the Latest News and Ratings for ISRG and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Intuitive Surgical and its competitors.

ISRG Analyst Ratings Over Time

Type	Current Forecast 12/14/23 to 12/13/24	1 Month Ago 11/14/23 to 11/13/24	3 Months Ago 9/15/23 to 9/14/24	1 Year Ago 12/14/22 to 12/14/23
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	15 Buy rating(s)	14 Buy rating(s)	15 Buy rating(s)	17 Buy rating(s)
Hold	3 Hold rating(s)	4 Hold rating(s)	5 Hold rating(s)	4 Hold rating(s)
Sell	1 Sell rating(s)	1 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$550.28	$513.74	$446.45	$342.95
Forecasted Upside	1.02% Upside	-4.28% Downside	-8.86% Downside	5.14% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy

Buffett’s Selling Out: Is Your 401(k) About to Get Wiped Out? (Ad)

Let me share something important with you. Just a few weeks ago, Warren Buffett unloaded $932 million worth of bank stocks. He didn't do it on a whim—he knows something big is coming. The question is: Why aren't you taking action, too?

Click Here For Your Free Guide

ISRG Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

ISRG Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Intuitive Surgical Stock vs. The Competition

Type	Intuitive Surgical	Medical Companies	S&P 500
Consensus Rating Score	2.74	2.81	2.50
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy
Predicted Upside	1.02% Upside	29,102.73% Upside	10.07% Upside
News Sentiment Rating	Positive News See Recent ISRG News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
12/11/2024	Citigroup 3 of 5 stars		Boost Target	Buy ➝ Buy	$567.00 ➝ $640.00	+17.72%
12/11/2024	Wells Fargo & Company 3 of 5 stars		Boost Target	Overweight ➝ Overweight	$549.00 ➝ $630.00	+15.49%
12/5/2024	Stifel Nicolaus 4 of 5 stars		Boost Target	Buy ➝ Buy	$525.00 ➝ $610.00	+11.22%
12/2/2024	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Equal Weight ➝ Overweight	$522.00 ➝ $650.00	+19.93%
11/26/2024	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$535.00 ➝ $561.00	+3.85%
11/19/2024	Erste Group Bank Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Hold ➝ Buy
Get the Latest News and Ratings for ISRG and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Intuitive Surgical and its competitors with MarketBeat's FREE daily newsletter.
10/18/2024	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	David Roman Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Target		$604.00	+15.73%
10/18/2024	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Market Perform ➝ Market Perform
10/18/2024	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Cautious ➝ Cautious
10/18/2024	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Overweight ➝ Overweight	$495.00 ➝ $538.00	+4.92%
10/18/2024	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Shagun Singh Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Outperform ➝ Outperform	$525.00 ➝ $555.00	+8.40%
10/17/2024	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating	Anthony Petrone Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target		$440.00 ➝ $500.00	+5.30%
10/17/2024	Leerink Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target		$489.00 ➝ $502.00	+5.72%
10/17/2024	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$503.00 ➝ $565.00	+18.98%
10/14/2024	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$500.00 ➝ $540.00	+11.06%
10/14/2024	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Richard Newitter Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Buy ➝ Buy	$520.00 ➝ $570.00	+17.78%
10/11/2024	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$495.00 ➝ $575.00	+18.52%
8/2/2024	Redburn Atlantic Subscribe to MarketBeat All Access for the recommendation accuracy rating	E. Ridley-Day Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Neutral ➝ Buy	$380.00 ➝ $510.00	+13.10%
7/18/2024	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$430.00 ➝ $490.00	+17.49%
4/19/2024	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Hold ➝ Hold	$365.00 ➝ $375.00	+0.64%
11/17/2023	HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy	$318.00	+4.62%
10/19/2023	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Neutral ➝ Neutral	$385.00 ➝ $314.00	+14.82%
5/31/2023	Sanford C. Bernstein Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target		$350.00 ➝ $365.00	+18.87%
4/19/2023	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Hold	$245.00 ➝ $290.00	-4.27%
4/19/2023	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy	$300.00 ➝ $315.00	+16.98%
3/23/2023	William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating	B. Vazquez Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Outperform
12/22/2022	Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy	$265.00 ➝ $320.00	+20.23%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 03:43 AM ET.

Should I Buy Intuitive Surgical Stock? ISRG Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Thursday, December 5, 2024. Please send any questions or comments about these Intuitive Surgical pros and cons to contact@marketbeat.com.

Intuitive Surgical
Bull Case

Here are some ways that investors could benefit from investing in Intuitive Surgical, Inc.:

Strong quarterly earnings: Intuitive Surgical, Inc. reported earnings per share (EPS) of $1.56, exceeding the consensus estimate of $1.24 by $0.32, indicating robust financial performance.
High revenue growth: The company generated $2.04 billion in revenue during the last quarter, surpassing analyst expectations of $2.01 billion, showcasing its ability to drive sales effectively.
Market capitalization: With a market cap of $191.82 billion, Intuitive Surgical, Inc. is a significant player in the medical equipment sector, which can provide stability and investor confidence.
Current stock price: The stock is currently trading around $542.06, reflecting a strong position within its 52-week range of $304.50 to $552.00, suggesting potential for continued growth.
High net margin: The company boasts a net margin of 28.51%, indicating efficient management and profitability, which can be attractive to investors looking for financially sound companies.

Intuitive Surgical
Bear Case

Investors should be bearish about investing in Intuitive Surgical, Inc. for these reasons:

High price-to-earnings (P/E) ratio: The P/E ratio stands at 86.58, which may suggest that the stock is overvalued compared to its earnings, potentially deterring value-focused investors.
Insider selling: Recent insider transactions indicate a significant amount of stock being sold, with insiders selling 50,459 shares worth over $26 million in the last quarter, which could signal a lack of confidence in the stock's future performance.
Beta of 1.39: This indicates that the stock is more volatile than the market, which could lead to larger price swings and increased risk for investors.
Price-to-earnings-growth (PEG) ratio: The PEG ratio of 5.28 suggests that the stock may be expensive relative to its growth rate, which could be a concern for growth-oriented investors.
Recent trading volume: The recent trading volume of 938,359 shares is significantly lower than the average volume of 1,455,400, which may indicate reduced investor interest or liquidity issues.

ISRG Forecast - Frequently Asked Questions

: According to the research reports of 19 Wall Street equities research analysts, the average twelve-month stock price forecast for Intuitive Surgical is $550.28, with a high forecast of $650.00 and a low forecast of $375.00.
: 19 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Intuitive Surgical in the last twelve months. There is currently 1 sell rating, 3 hold ratings and 15 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" ISRG shares.
: According to analysts, Intuitive Surgical's stock has a predicted upside of 1.02% based on their 12-month stock forecasts.
: Over the previous 90 days, Intuitive Surgical's stock had 2 upgrades by analysts.
: Intuitive Surgical has been rated by research analysts at BTIG Research, Citigroup, Erste Group Bank, Evercore ISI, JPMorgan Chase & Co., Leerink Partners, Mizuho, Morgan Stanley, Oppenheimer, Piper Sandler, Raymond James, Robert W. Baird, Royal Bank of Canada, Stifel Nicolaus, The Goldman Sachs Group, Truist Financial, and Wells Fargo & Company in the past 90 days.
: Analysts like Intuitive Surgical less than other "medical" companies. The consensus rating score for Intuitive Surgical is 2.74 while the average consensus rating score for "medical" companies is 2.81. Learn more on how ISRG compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

Traders! Get Ready to have your Mind BLOWN on DEC 13th!! (Ad)

There is a Silver stock that is sliding past the street and it deserves your full attention! Gold has seen a CRAZY year in 2024 and silver has A LOT more room to move. Sign up NOW and get ready for our biggest NYSE Stock alert of 2024 that's Coming Dec 13th!

Do not wait any longer traders..

This page (NASDAQ:ISRG) was last updated on 12/13/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Intuitive Surgical (ISRG) Stock Forecast & Price Target